Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Condition: Cutaneous Squamous Cell Carcinoma Intervention: Drug: Imgatuzumab Sponsors: Pega-One S.A.S.; ICON plc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials